CVE-2026-62217 OpenClaw 2026.5.14-beta.1 < 2026.5.27 Authentication Bypass via exec approvals
Attackers can bypass authorization in OpenClaw's QQBot exec approvals to execute unauthorized actions if the feature is enabled.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- Available
What is CVE-2026-62217?
CVE-2026-62217 is a high-severity authentication bypass vulnerability in Openclaw Openclaw, published on 17 Jul 2026. Any signed-in user can exploit it over the network, with no action from the victim.
Official description
OpenClaw 2026.5.14-beta.1 before 2026.5.27 contain an authorization flaw in the QQBot exec approvals feature. When the feature is enabled and reachable, a lower-trust caller or configured input path could execute or persist actions beyond the caller's intended authorization, allowing non-allowlisted senders to perform unauthorized operations.
Weakness: CWE-863
Which versions are affected by CVE-2026-62217?
It affects 1 product.
Products include Openclaw Openclaw.
How do I fix CVE-2026-62217?
Upgrade to a fixed version.
Upgrade, and rotate credentials and sessions that may have been exposed. More about Authentication bypass.
Is CVE-2026-62217 being exploited?
There is no known exploitation of CVE-2026-62217 in the wild and no public exploit code.
Other vulnerabilities in Openclaw Openclaw
- CVE-2026-28363 Security feature bypass in OpenClaw
- CVE-2026-30741 Code injection in n/a
- CVE-2026-33579 OpenClaw < 2026.3.28 - Privilege Escalation via Missing Caller Scope Validation in Device Pair Approval
- CVE-2026-32922 OpenClaw < 2026.3.11 - Privilege Escalation via Unvalidated Scope in device.token.rotate
- CVE-2026-32978 OpenClaw < 2026.3.11 - Approval Bypass via Unrecognized Script Runners
Sources
Also known as GHSA-7jx6-764p-fgg9, GHSA-rv8f-q23g-2wjx, MINI-j3j6-647w-v9gx.